+
+
Stay Informed

Structural Interventions

The Amplatzer™ portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The procedures are performed through a minimally invasive, transcatheter approach, which prevents the need for open heart surgery and helps facilitate faster recovery and lower complication rates. The Amplatzer line has built a reputation for innovation by pioneering structural heart defect occluder devices and remains the leader in treatment worldwide.

Structural Interventions

The Amplatzer™ portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The procedures are performed through a minimally invasive, transcatheter approach, which prevents the need for open heart surgery and helps facilitate faster recovery and lower complication rates. The Amplatzer line has built a reputation for innovation by pioneering structural heart defect occluder devices and remains the leader in treatment worldwide.

Thanks to the vision of our founder, Dr. Kurt Amplatz, and the bold, committed physicians who built upon his work, a device was pioneered that could close the holes in the hearts of the tiniest babies: the Amplatzer Piccolo™ Occluder. Watch how we carry on this exciting legacy today.

Amplatzer Amulet Occluder for atrial fibrillation and ischemic stroke risk

AMPLATZER™ AMULET™ LEFT ATRIAL APPENDAGE OCCLUDER

The Amplatzer Amulet LAA Occluder is designed to treat patients with atrial fibrillation who are at risk of ischemic stroke. The device offers immediate closure1of the left atrial appendage (LAA), reducing the risk of stroke and immediately eliminating the need for oral anticoagulants.2

Learn more about the Amplatzer Amulet LAA Occluder

AMPLATZER™ TALISMAN™ PFO OCCLUDER

STROKE RISK REDUCTION

The Amplatzer PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke.3 The Amplatzer Talisman PFO Occluder is built off this proven technology, with key enhancements to make it our most advanced and easy-to-use PFO closure device yet. With over 180,000 devices implanted worldwide,2 we are the leader in PFO closure.

Learn more about the Amplatzer Talisman PFO Occluder

Amplatzer Talisman PFO Occluder for patent foramen ovale closure
Amplatzer Talisman PFO Occluder for patent foramen ovale closure

AMPLATZER™ TALISMAN™ PFO OCCLUDER

STROKE RISK REDUCTION

The Amplatzer PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke.3 The Amplatzer Talisman PFO Occluder is built off this proven technology, with key enhancements to make it our most advanced and easy-to-use PFO closure device yet. With over 180,000 devices implanted worldwide,2 we are the leader in PFO closure.

Learn more about the Amplatzer TALISMAN PFO Occluder

Amplatzer Septal Occluder for atrial septal defect closure

AMPLATZER™ SEPTAL OCCLUDER

CONGENITAL DEFECTS

The Amplatzer Septal Occluder is the standard of care for minimally invasive atrial septal defect (ASD) closure, with a variety of shapes, sizes, and features that facilitate precise placement. It is the most studied ASD closure device available today, with over 20 years of demonstrated clinical experience.4,5

Learn more about the Amplatzer Septal Occluder

AMPLATZER™ DUCT OCCLUDERS

CONGENITAL DEFECTS

The Amplatzer family of duct occluders offers an extensive line of devices for the closure of patent ductus arteriosus (PDA). Amplatzer Duct Occluders are designed to occlude PDAs of various shapes and sizes to meet the needs of your patients.

Learn more about Amplatzer Duct Occluders

Amplatzer Duct Occluder for patent ductus arteriosus closure
Amplatzer Duct Occluder for patent ductus arteriosus closure

AMPLATZER™ DUCT OCCLUDERS

CONGENITAL DEFECTS

The Amplatzer family of duct occluders offers an extensive line of devices for the closure of patent ductus arteriosus (PDA). Amplatzer Duct Occluders are designed to occlude PDAs of various shapes and sizes to meet the needs of your patients.

Learn more about Amplatzer Duct Occluders

Amplatzer Muscular VSD Occluder for ventricular septal defects

AMPLATZER™ VSD OCCLUDERS

CONGENITAL DEFECTS

Ventricular septal defects (VSD) are the most common congenital heart defect,6 and one subtype of these defects is muscular VSD. The Amplatzer Muscular VSD Occluders are designed for complete closure of these type of defects.

Learn more about Amplatzer VSD Occluders

AMPLATZER™ VALVULAR PLUG III

PARAVALVULAR LEAK

The Amplatzer™ Valvular Plug III is specially designed to provide effective closure for patients with a wide range of paravalvular leak morphologies. By providing an effective solution to this key issue, the Amplatzer Valvular Plug III improving life, quality and longevity to an increasing number of patients.7,8,9,10

Learn more about Amplatzer VALVULAR PLUG III

Amplatzer Valvular Plug III for paravalvular leak
Amplatzer Valvular Plug III for paravalvular leak

AMPLATZER™ VALVULAR PLUG III

PARAVALVULAR LEAK

The Amplatzer™ Valvular Plug III is specially designed to provide effective closure for patients with a wide range of paravalvular leak morphologies. By providing an effective solution to this key issue, the Amplatzer Valvular Plug III improving life, quality and longevity to an increasing number of patients.7,8,9,10

Learn more about Amplatzer VALVULAR PLUG III

MAT-2201554 v2.0 | Item approved for OUS use only.

References
  1. Test performed by and data on file at Abbott.
  2. Amplatzer Amulet LAA Occluder Instructions for Use.
  3. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-32. doi: 10.1056/NEJMoa1610057
  4. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42:388-393.
  5. Amplatzer Septal Occluder Instructions for Use.
  6. Hoffman J, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. doi: 10.1016/s0735-1097(02)01886-7 
  7. Calvert et al. Percutaneous device closure of paravalvular leak. Circulation. 2016;134(13):934-944.
  8. Yildirim A, Goktekin O, Gorgulu S, et al. A new specific device in transcatheter prosthetic paravalvular leak closure: a prospective two-center trial. Catheter Cardiovasc Interv. 2016;88(4):618-624.
  9. Smolka G, Pysz P, Kozłowski M, et al. Transcatheter closure of paravalvular leaks using a paravalvular leak device - a prospective Polish registry. Postepy Kardiol Interwencyjnej. 2016;12(2):128-134.
  10. Angulo-Llanos R, Sarnago-Cebada F, Rivera AR, et al. Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2016;88(4):626-634.
  11. Data on file at Abbott.
Abbott Logo

Follow Abbott

Copyright © 2024 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: Product(s) are intended for use by or under the direction of a physician. Prior to use, reference to the Instructions for Use, inside the product carton (when available) or at www.eifu.abbott for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v18.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. Health Care Professionals International Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+